Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3763-3767

  Chiyo, Masako ^a,b   Shimozato, Osamu ^a   Iizasa, Toshihiko ^b   Fujisawa, Takehiko ^b   Tagawa, Masatoshi ^a,b  

^a CHIBA CANCER CENTER   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Cytokine gene therapy; IL 12; IL 23; IL 27

Indexed keywords

CYTOKINE; DIMER; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; IL23A PROTEIN, MOUSE; INTERLEUKIN 23P19; INTERLEUKIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOMA CELL; CELL ACTIVATION; CELL MATURATION; CELL POPULATION; CELLULAR IMMUNITY; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG POTENTIATION; FEMALE; GENE EXPRESSION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE; TARGET CELL; TUMOR GROWTH; ADOPTIVE IMMUNOTHERAPY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COLON TUMOR; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DENDRITIC CELLS; FEMALE; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-12; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; MICE; MICE, INBRED BALB C; TRANSDUCTION, GENETIC;

EID: 14944367061     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tagawa M: Cytokine therapy for cancer. Curr Pharm Des 6: 681-699, 2000.
2. Roth JA and Cristiano RJ: Gene therapy for cancer: What have we done and where are we going? J Natl Cancer Inst 89: 21-39, 1997.
3. Abbas AK, Murphy KM and Sher A: Functional diversity of helper T lymphocytes. Nature 285: 787-793, 1996
4. Brombacher F, Kastelein RA and Alber G: Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol 24: 207-212, 2003.
5. Oppmann B, Lesley R, Blom B et al: Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725, 2000.
6. + T cells. Immunity 16: 779-790, 2002.
7. Tasaki K, Yoshida Y, Maeda T et al: Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Cancer Gene Ther 7: 247-254, 2000.
8. Wang Y-Q, Ugai S, Shimozato O et al: Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells. Int J Cancer 105: 820-824, 2003.
9. Nieuwenhuis EE, Neurath MF, Corazza N et al: Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc Natl Acad Sci USA 99: 16951-16956, 2002.
10. Duke GM, Hoffman MA and Palmenberg AC: Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol 66: 1602-1609, 1992.
11. Hisada M, Kamiya S, Fujita K et al: Potent antitumor activity of interleukin-27. Cancer Res 64: 1152-1156, 2004.
12. Kawamura K, Bahar R, Natsume W, Sakiyama S and Tagawa T: Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic anti-tumor immunity and impairs protective immunity induced against the tumors. Cancer Gene Ther 9: 109-115, 2002.
13. Villarino A, Hibbert L, Lieberman L et al: The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655, 2003.
14. Hamano S, Himeno K, Miyazaki Y et al: WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19: 657-667, 2003.
15. Chen Q, Ghilardi N, Wang H et al: Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407: 916-920, 2000.
16. Yoshida H, Hamano S, Senaldi G et al: WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15: 569-578, 2001.
17. Cua DJ, Sherlock J, Chen Y et al: Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748, 2003.
18. Mantovani A, Bottazzi B, Colotta F, Sozzani S and Ruco L: The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270, 1992.
19. Richter G, Krüger-Krasagakes S, Hein G et al: Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res 53: 4134-4137, 1993.